1.Serratus Anterior Plane Block: A Better Modality of Pain Control after Pectus Excavatum Repair
Eun Seok KA ; Gong Min RIM ; Seungyoun KANG ; Saemi BAE ; Il-Tae JANG ; Hyung Joo PARK
Journal of Chest Surgery 2024;57(3):291-299
Background:
Postoperative pain management following minimally invasive repair of pectus excavatum (MIRPE) remains a critical concern due to severe post-procedural pain.Promising results have been reported for cryoanalgesia following MIRPE; however, its invasiveness, single-lung ventilation, and additional instrumentation requirements remain obstacles. Serratus anterior plane block (SAPB) is a regional block technique capable of covering the anterior chest wall at the T2–9 levels, which are affected by MIRPE. We hypothesized that SAPB would be a superior alternative pain control modality that reduces postoperative pain more effectively than conventional methods.
Methods:
We conducted a retrospective study of patients who underwent MIRPE between March 2022 and August 2023. The efficacy of pain control was compared between group N (conventional pain management, n=24) and group S (SAPB, n=26). Group N received intravenous patient-controlled analgesia (IV-PCA) and subcutaneous local anesthetic infusion. Group S received bilateral continuous SAPB with 0.3% ropivacaine after a bilateral bolus injection of 30 mL of 0.25% ropivacaine with baseline IV-PCA. Pain levels were evaluated using a Visual Analog Scale (VAS) at 1, 3, 6, 12, 24, 48, and 72 hours postoperatively and total intravenous rescue analgesic consumption by morphine milligram equivalents (MME).
Results:
Mean VAS scores were significantly lower in group S than in group N throughout the 72-hour postoperative period (p<0.01). Group S showed significantly lower MME at postoperative 72 hours (group N: 108.53, group S: 16.61; p<0.01).
Conclusion
SAPB improved immediate postoperative pain control in both the resting and dynamic states and reduced opioid consumption compared to conventional management.
2.Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms
Young Sun LEE ; Yeon Seok SEO ; Ji Hoon KIM ; Juneyoung LEE ; Hae Rim KIM ; Yang Jae YOO ; Tae Suk KIM ; Seong Hee KANG ; Sang Jun SUH ; Moon Kyung JOO ; Young Kul JUNG ; Beom Jae LEE ; Hyung Joon YIM ; Jong Eun YEON ; Jae Seon KIM ; Jong Jae PARK ; Soon Ho UM ; Young Tae BAK ; Kwan Soo BYUN
Gut and Liver 2018;12(1):94-101
BACKGROUND/AIMS: In addition to the globally endorsed Barcelona Clinic Liver Cancer (BCLC) staging system, other algorithms or staging systems have been developed, including the Hong Kong Liver Cancer (HKLC) staging system. This study aimed to validate the HKLC staging system relative to the BCLC staging system for predicting survival for hepatocellular carcinoma (HCC) patients in Korea. METHODS: From 2004 to 2013, 2,571 patients newly diagnosed with HCC were consecutively enrolled at three Korea University medical centers. RESULTS: Both staging systems differentiated survival well (p < 0.001). However, 1-year and 3-year survival were predicted better using the HKLC system than the BCLC system (area under the receiver operating characteristic curve: 0.869 vs 0.856 for 1 year, p=0.002; 0.841 vs 0.827 for 3 years, p=0.010). In hypothetical survival curves, the HKLC system exhibited better median overall survival than the BCLC system (33.1 months vs 19.2 months). In evaluations of prognosis according to either BCLC or HKLC treatment guidelines, risk of death was reduced in the group following only HKLC guidelines compared with the group following only BCLC guidelines (hazard ratio, 0.601; 95% confidence interval, 0.443 to 0.816; p=0.001). CONCLUSIONS: Although both staging systems predicted and discriminated HCC prognoses well, the HKLC system showed more encouraging survival benefits than the BCLC system.
Academic Medical Centers
;
Carcinoma, Hepatocellular
;
Hong Kong
;
Humans
;
Korea
;
Liver Neoplasms
;
Liver
;
Neoplasm Staging
;
Prognosis
;
ROC Curve
3.Determinants of North Korean Refugees' Trust in South Korea Health Service
Tae Rim UM ; Ha Ju MIN ; Tae Ho LEE ; Eun Joo LEE ; Ki Nam JIN
Health Policy and Management 2018;28(1):70-76
BACKGROUND: The purpose of this study was to investigate the determinants of North Korean refugees' trust in South Korea health service. METHODS: This study surveyed 168 North Korean refugees aged 19 and over living in Seoul, Gyeonggi, Incheon, and Gangwon. The collected data were analyzed by frequency analysis, t-test, analysis of variance, and hierarchical regression analysis to analyze the effect on the trust of refugees. RESULTS: The difference analysis showed statistically significant difference according to duration of residence and employment status. The determinants of North Korean refugees' trust in South Korea health services were duration of residence, basic communication skills, health communication skills, and experience of health service. CONCLUSION: In order to increase the trust of North Korean defectors in South Korea medical services, it is necessary to resolve communication problems and improve the satisfaction of health services. For this, the interpreter service should be activated. And specific education should be given to the North Korean refugees about the health care system and the utilization methods of health service in Korea.
Delivery of Health Care
;
Education
;
Employment
;
Gangwon-do
;
Gyeonggi-do
;
Health Communication
;
Health Services
;
Humans
;
Incheon
;
Korea
;
Refugees
;
Seoul
4.The Utility of Preliminary Patient Evaluation in a Febrile Respiratory Infectious Disease Unit outside the Emergency Department.
Jun Sik KANG ; Byung Woo JHUN ; Hee YOON ; Seong Mi LIM ; Eunsil KO ; Joo Hyun PARK ; Sung Yeon HWANG ; Se Uk LEE ; Tae Rim LEE ; Won Chul CHA ; Tae Gun SHIN ; Min Seob SIM ; Ik Joon JO
Journal of Korean Medical Science 2017;32(9):1534-1541
A febrile respiratory infectious disease unit (FRIDU) with a negative pressure ventilation system was constructed outside the emergency department (ED) of the Samsung Medical Center in 2015, to screen for patients with contagious diseases requiring isolation. We evaluated the utility of the FRIDU during 1 year of operation. We analyzed 1,562 patients who were hospitalized after FRIDU screening between August 2015 and July 2016. The level of isolation recommended during their screening at the FRIDU was compared with the level deemed appropriate given their final diagnosis. Of the 1,562 patients screened at the FRIDU, 198 (13%) were isolated, 194 (12%) were reverse isolated, and 1,170 (75%) were not isolated. While hospitalized, 97 patients (6%) were confirmed to have a contagious disease requiring isolation, such as tuberculosis; 207 patients (13%) were confirmed to be immunocompromised and to require reverse isolation, mainly due to neutropenia; and the remaining 1,258 patients (81%) did not require isolation. The correlation coefficient for isolation consistency was 0.565 (P < 0.001). The sensitivity and negative predictive value of FRIDU screening for diagnosing contagious disease requiring isolation are 76% and 98%, respectively. No serious nosocomial outbreaks of contagious diseases occurred. During FRIDU screening, 114 patients were admitted to the resuscitation zone due to clinical instability, and three of these patients died. The initial isolation levels resulting from FRIDU screening were moderately well correlated with the isolation levels required by the final diagnosis, demonstrating the utility of pre-hospitalization screening units. However, the risks of deterioration during the screening process remain challenges.
Communicable Diseases*
;
Diagnosis
;
Disease Outbreaks
;
Emergencies*
;
Emergency Service, Hospital*
;
Humans
;
Mass Screening
;
Neutropenia
;
Resuscitation
;
Tuberculosis
;
Ventilation
5.Hepatic Infarction Caused by Portal Vein Thrombophlebitis Misdiagnosed as Infiltrative Hepatic Malignancy with Neoplastic Thrombus.
Minjung SHIM ; Tae Young YANG ; Nam Gil CHO ; Ara WOO ; Eunju KIM ; Keunhoi PARK ; Joo Ho LEE ; Yun Bin LEE ; Seong Gyu HWANG ; Kyu Sung RIM ; Hana PARK
The Korean Journal of Gastroenterology 2016;68(3):156-160
Portal vein thrombosis (PVT) is a form of venous thrombosis that usually presents in chronic form without any sequalae in patients with hepatocellular carcinoma (HCC) or liver cirrhosis. Accurate differential diagnosis of bland PVT from neoplastic PVT is an important step for planning treatment options, but the acute form can be challenging. Here we present a case of acute hepatic infarction caused by acute bland PVT combined with pylephlebitis, which was misdiagnosed as infiltrative hepatic malignancy with neoplastic PVT owing to the perplexing imaging results and elevated tumor markers.
Biomarkers, Tumor
;
Carcinoma, Hepatocellular
;
Diagnosis, Differential
;
Hepatitis B, Chronic
;
Humans
;
Infarction*
;
Liver Cirrhosis
;
Portal Vein*
;
Tenofovir
;
Thrombophlebitis*
;
Thrombosis*
;
Venous Thrombosis
6.The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
Tae Rim SHIN ; Yeon Mok OH ; Joo Hun PARK ; Keu Sung LEE ; Sunghee OH ; Dae Ryoung KANG ; Seungsoo SHEEN ; Joon Beom SEO ; Kwang Ha YOO ; Ji Hyun LEE ; Tae Hyung KIM ; Seong Yong LIM ; Ho Il YOON ; Chin Kook RHEE ; Kang Hyeon CHOE ; Jae Seung LEE ; Sang Do LEE
Journal of Korean Medical Science 2015;30(10):1459-1465
The prognostic role of resting pulmonary hyperinflation as measured by residual volume (RV)/total lung capacity (TLC) in chronic obstructive pulmonary disease (COPD) remains poorly understood. Therefore, this study aimed to identify the factors related to resting pulmonary hyperinflation in COPD and to determine whether resting pulmonary hyperinflation is a prognostic factor in COPD. In total, 353 patients with COPD in the Korean Obstructive Lung Disease cohort recruited from 16 hospitals were enrolled. Resting pulmonary hyperinflation was defined as RV/TLC > or = 40%. Multivariate logistic regression analysis demonstrated that older age (P = 0.001), lower forced expiratory volume in 1 second (FEV1) (P < 0.001), higher St. George Respiratory Questionnaire (SGRQ) score (P = 0.019), and higher emphysema index (P = 0.010) were associated independently with resting hyperinflation. Multivariate Cox regression model that included age, gender, dyspnea scale, SGRQ, RV/TLC, and 6-min walking distance revealed that an older age (HR = 1.07, P = 0.027), a higher RV/TLC (HR = 1.04, P = 0.025), and a shorter 6-min walking distance (HR = 0.99, P < 0.001) were independent predictors of all-cause mortality. Our data showed that older age, higher emphysema index, higher SGRQ score, and lower FEV1 were associated independently with resting pulmonary hyperinflation in COPD. RV/TLC is an independent risk factor for all-cause mortality in COPD.
Aged
;
Dyspnea/diagnosis/physiopathology
;
Exercise Test
;
Exercise Tolerance
;
Female
;
Forced Expiratory Flow Rates/physiology
;
Forced Expiratory Volume
;
Humans
;
Lung/*physiopathology
;
Male
;
Middle Aged
;
Prognosis
;
Pulmonary Disease, Chronic Obstructive/*diagnosis/mortality/physiopathology
;
Pulmonary Emphysema/*diagnosis/mortality/physiopathology
;
Republic of Korea
;
Residual Volume/*physiology
;
Respiratory Function Tests
;
Surveys and Questionnaires
;
Total Lung Capacity/*physiology
;
Vital Capacity
;
Walking/physiology
7.A Case of Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis.
Tae Young YANG ; Suk Pyo SHIN ; Joo Ho LEE ; Yun Bin LEE ; Hana PARK ; Seong Gyu HWANG ; Kyu Sung RIM
Journal of Liver Cancer 2015;15(1):52-56
Patients with advanced hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) have an extremely poor prognosis. Although the Barcelona Clinic Liver Cancer guideline recommends sorafenib in advanced HCC with PVT, which has provided survival benefits of 2 or 3 months compared to the placebo group, many liver cancer centers in Asia still select multimodality approaches including transarterial chemoembolization, radiofrequency ablation, radiation therapy (RT) as well as systemic/intra-arterial chemotherapy. Recently advanced RT technologies have shown potential to improve survival without severe radiation-related toxicity. For locally advanced HCC patients with PVT, concurrent chemoradiotherapy (CCRT) has been applied as a loco-regional treatment and provides potential cures. We herein report our recent experience of a patient accompanying large HCC with PVT who successfully undergone CCRT followed by hepatic arterial infusion chemotherapy.
Asia
;
Carcinoma, Hepatocellular*
;
Catheter Ablation
;
Chemoradiotherapy
;
Drug Therapy
;
Humans
;
Liver Neoplasms
;
Portal Vein*
;
Prognosis
;
Venous Thrombosis*
8.Association of body mass index with airway hyperresponsiveness and lung function in adult asthmatics.
Jung Eun CHOI ; Tae Rim SHIN ; Sang Myeon PARK ; Joo Hee KIM ; Sung Ho SHIN ; Hyun Young LEE ; Juah JANG ; Hun Gu LEE ; Cheol Hong KIM ; In Gyu HYUN ; Jeong Hee CHOI
Allergy, Asthma & Respiratory Disease 2014;2(1):16-22
PURPOSE: Obesity is commonly regarded as a risk factor for asthma development, poor asthma control, and poor response to asthma therapy. However, its relationships are not always consistent. Gender difference has been reported to influence asthma severity and asthma control. We investigated the contribution of obesity to airway hyperresponsiveness (AHR) and lung function before and after treatment in adult asthmatics. METHODS: The medical records of a total of 323 adult asthmatics were analyzed retrospectively. Asthma was diagnosed based on the positive result of methacholine bronchial provocation test (PC20< or =25 mg/mL) or bronchodilator test (> or =12% and 200-mL improvement in forced expiratory volume in 1 second after inhalation of a bronchodilator). Follow-up spirometry was performed in 113 patients after at least 3 months of asthma treatment with controller medication. Percent change between spirometry before and after treatment was defined as {[(value after treatment-value before treatment)/value before treatment]x100}. Body mass index (BMI, weight [kg]/height [m2]) was categorized into underweight (<18.5), normal weight (18.5-24.9), overweight (25.0-29.9), and obese (>30) according to the world health organization classification. RESULTS: BMI did not show any significant correlation with PC20 value of methacholine provocation test and each lung function parameter before and after treatment. When we divided the study subjects according to gender and age, BMI was negatively correlated with PC20 value only in female adult asthmatics under 65 years old (r=-0.024, P=0.036). CONCLUSION: Obesity is positively correlated with the intensity of AHR in female adult asthmatics. Gender seems to differentially contribute to the relationship between BMI and AHR.
Adult*
;
Aged
;
Asthma
;
Body Mass Index*
;
Bronchial Provocation Tests
;
Classification
;
Female
;
Follow-Up Studies
;
Forced Expiratory Volume
;
Humans
;
Inhalation
;
Lung*
;
Medical Records
;
Methacholine Chloride
;
Obesity
;
Overweight
;
Retrospective Studies
;
Risk Factors
;
Spirometry
;
Thinness
;
World Health Organization
9.Tracheoesophageal Fistula with Tracheal Dilatation in a Patient with a Tracheostomy Using a Home Mechanical Ventilator.
Byounghoon KIM ; Min Sun JOO ; Yoo Na KIM ; Tae Rim SHIN ; Sang Myeon PARK ; Dong Gyu KIM ; Yun Su SIM
Korean Journal of Medicine 2014;87(1):87-91
Patients with tracheostomies requiring prolonged home mechanical ventilation are increasing in number rapidly. A tracheoesophageal fistula is a relatively unusual complication, but this case resulted in a fatal outcome. We describe a tracheoesophageal fistula with tracheal dilation in a 72-year-old female who had a prolonged tracheostomy and nasogastric tube, using a home mechanical ventilator. On enhanced CT images, the tracheostomy tube was well located within the trachea with no abnormal finding. However, chest enhanced CT images obtained 5 months later showed marked circumferential wall thickening of the trachea with tiny ulceration, a markedly increased diameter of the tracheal lumen, and a tracheoesophageal fistula. In patients using home mechanical ventilators, the location and cuff pressure of the tracheostomy tube and the nasogastric tube should be evaluated routinely.
Aged
;
Dilatation*
;
Fatal Outcome
;
Female
;
Humans
;
Respiration, Artificial
;
Thorax
;
Trachea
;
Tracheoesophageal Fistula*
;
Tracheostomy*
;
Ulcer
;
Ventilators, Mechanical*
10.Efficacy and safety of entecavir plus carnitine complex (GODEX(R)) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.
Dae Won JUN ; Byung Ik KIM ; Yong Kyun CHO ; Hong Ju KIM ; Young Oh KWON ; Soo Young PARK ; Sang Young HAN ; Yang Hyun BAEK ; Yong Jin JUNG ; Hwi Young KIM ; Won KIM ; Jeong HEO ; Hyun Young WOO ; Seong Gyu HWANG ; Kyu Sung RIM ; Jong Young CHOI ; Si Hyun BAE ; Young Sang LEE ; Young Suck LIM ; Jae Youn CHEONG ; Sung Won CHO ; Byung Seok LEE ; Seok Hyun KIM ; Joo Hyun SOHN ; Tae Yeob KIM ; Yong Han PAIK ; Ja Kyung KIM ; Kwan Sik LEE
Clinical and Molecular Hepatology 2013;19(2):165-172
BACKGROUND/AIMS: Carnitine and vitamin complex (Godex(R)) is widely used in patients with chronic liver disease who show elevated liver enzyme in South Korea. The purpose of this study is to identify the efficacy and safety of carnitine from entecavir combination therapy in Alanine aminotransferase (ALT) elevated Chronic Hepatitis B (CHB) patients. METHODS: 130 treatment-naive patients with CHB were enrolled from 13 sites. The patients were randomly selected to the entecavir and the complex of entecavir and carnitine. The primary endpoint of the study is ALT normalization level after 12 months. RESULTS: Among the 130 patients, 119 patients completed the study treatment. The ALT normalization at 3 months was 58.9% for the monotherapy and 95.2% for the combination therapy (P<0.0001). ALT normalization rate at 12 months was 85.7% for the monotherapy and 100% for the combination group (P=0.0019). The rate of less than HBV DNA 300 copies/mL at 12 months was not statistically significant (P=0.5318) 75.9% for the monotherapy, 70.7% for the combination and it was. Quantification of HBsAg level was not different from the monotherapy to combination at 12 months. Changes of ELISPOT value to evaluate the INF-gamma secretion by HBsAg showed the increasing trend of combination therapy compare to mono-treatment. CONCLUSIONS: ALT normalization rate was higher in carnitine complex combination group than entecavir group in CHB. Combination group was faster than entecavir mono-treatment group on ALT normalization rate. HBV DNA normalization rate and the serum HBV-DNA level were not changed by carnitine complex treatment.
Adult
;
Alanine Transaminase/blood
;
Antiviral Agents/*therapeutic use
;
Carnitine/*therapeutic use
;
DNA, Viral/analysis
;
Drug Therapy, Combination
;
Enzyme-Linked Immunospot Assay
;
Female
;
Guanine/*analogs & derivatives/therapeutic use
;
Hepatitis B Surface Antigens/blood
;
Hepatitis B e Antigens/blood
;
Hepatitis B virus/genetics
;
Hepatitis B, Chronic/*drug therapy
;
Humans
;
Interferon-gamma/metabolism
;
Male
;
Middle Aged
;
Mitochondria/physiology
;
Treatment Outcome
;
Vitamin B Complex/*therapeutic use

Result Analysis
Print
Save
E-mail